MedPage Today on MSN
CAR7 gene therapy shows promise in T-cell ALL
The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...
Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...
Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy ...
CAR-T cell therapy provides long, treatment-free remissions for relapsed multiple myeloma, using genetically modified T cells ...
The cell company sponsors races in Las Vegas and—coming in 2026—Austin, rolling out Gen Z influencers and fan experiences for ...
Here are the top 5 most-read SAP articles in 2025. 5. With Remote Patient Monitoring, Picking Tools Is Easier Than Change ...
True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...
Ford says it is contributing more to Red Bull’s new Formula 1 engines than originally discussed, which is linked to the Blue ...
Hosted on MSN
Inside the ultimate Formula 1 experience
How much does it really cost to experience Formula 1 at the highest level? In this video, I take you inside the world’s most expensive F1 ticket, showing what you get for the price — from exclusive ...
Do you think everyone takes things a little too seriously? You’re likely Gen X. You are fluent in sarcasm. When someone makes ...
In a rare - but unavoidable - public appearance, Caroline Kennedy's jaw was set in a sombre grimace as she descended the ...
Immune cells are most commonly engineered to kill cancers, but now, scientists have shown the technique makes the gut lining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results